JANE STREET GROUP, LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 85 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$41,245
+47.3%
41,295
+162.3%
0.00%
Q3 2022$28,000
-26.3%
15,742
+19.2%
0.00%
Q2 2022$38,000
-87.1%
13,201
-79.1%
0.00%
Q4 2021$294,000
+209.5%
63,142
+464.1%
0.00%
Q3 2021$95,000
-83.9%
11,193
-68.9%
0.00%
Q2 2021$591,000
-77.1%
36,000
-69.2%
0.00%
-100.0%
Q1 2021$2,583,000
+63.8%
116,940
+129.4%
0.00%
Q4 2020$1,577,00050,9780.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$62,221,00018.51%
MPM BioImpact LLC 3,370,982$51,778,00013.77%
Redmile Group, LLC 1,765,188$27,113,0000.50%
ArrowMark Colorado Holdings LLC 1,356,010$20,828,0000.22%
DAFNA Capital Management LLC 46,183$709,0000.20%
Artal Group S.A. 350,000$5,376,0000.15%
WFA of San Diego, LLC 4,733$540,0000.13%
Granite Point Capital Management, L.P. 100,000$1,536,0000.08%
HHLR ADVISORS, LTD. 322,903$4,960,0000.04%
SPHERA FUNDS MANAGEMENT LTD. 30,000$461,0000.04%
View complete list of TCR2 THERAPEUTICS INC shareholders